Roll Call: NY A02904 | 2019-2020 | General Assembly
For additional roll call votes on New York A02904 please see the Vote List
Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]
Text: Latest bill text (Introduced) [HTML]
Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]
Text: Latest bill text (Introduced) [HTML]
Vote: Assembly Insurance Committee: Favorable refer to committee Codes
Vote | Tally | Democrat | Republican |
---|---|---|---|
Yea | 23 | 17 | 6 |
Nay | - | - | - |
Not Voting | - | - | - |
Absent | 1 | - | 1 |
TOTAL | 24 | 17 | 7 |